No Performance Benefits of Combined Mangiferin and Quercetin Supplementation in Cycling Athletes
Scandinavian Journal of Medicine & Science in Sports · 2025
DOI: 10.1111/sms.70148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Medicine & Science in Sports, 2025. Verfasst von Oscar Brogaard Mazza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Quercetin, Xanthones, Athletic Performance, Bicycling. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Sylvan Adams Sports Institute in Tel Aviv, Israel.
Abstract (Originalsprache)
The flavonoids mangiferin and quercetin are known for their antioxidant properties. The purpose of this study was to investigate the effects of combined mangiferin and quercetin (MQ) supplementation during prolonged intermittent cycling on sprint performance and 15‐min time trial performance (15‐min TT). Fourteen trained male endurance athletes (age 26 ± 5 years; body mass 80.7 ± 4.8 kg; stature 184 ± 7 cm; V̇O 2 peak, 63.0 ± 8.9 mL min −1 kg −1 ), initially completed a 15‐min TT in a fresh state to determine their maximal mean power output (MPO 15 ). On two separate days, participants then completed a 4‐h intermittent cycling protocol at 60% of MPO 15 , interspersed by 6‐ and 15‐s maximal sprints every hour, as well as 30‐s intervals at 120% of MPO 15 twice per hour. Upon completion of each protocol, participants immediately performed another 15‐min TT. During the 4‐h protocol, participants consumed 100 g CHO·h −1 . In addition, participants consumed 14.6 mg h −1 of mangiferin and 23.9 mg h −1 of quercetin in one of the trials, mixed into the CHO solution. Both trials showed similar reductions in 6‐s peak power (MQ: −59 ± 82 W; Control: −42 ± 75 W, time effect: p = 0.007) and 15‐s average power (MQ: −37 ± 50 W; Control: −19 ± 35 W, time effect: p = 0.02) during the 4‐h protocol (trial × time: p = 0.35 and 0.34, respectively). Additionally, no difference was observed between the two conditions in 15‐min TT performance following the 4‐h protocols (MQ: 339 ± 56 W; Control: 341 ± 54 W, p = 0.61). In conclusion, combined mangiferin and quercetin supplementation during prolonged intermittent cycling did not affect sprint or time trial performance in trained endurance athletes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Kasper Degn Gejl
Förderung
- Sylvan Adams Sports Institute in Tel Aviv, Israel
Zitieren
APA
Mazza, O. B., Lundby, C., & Gejl, K. D. (2025). No Performance Benefits of Combined Mangiferin and Quercetin Supplementation in Cycling Athletes. Scandinavian Journal of Medicine & Science in Sports. https://doi.org/10.1111/sms.70148
Vancouver
Mazza OB, Lundby C, Gejl KD. No Performance Benefits of Combined Mangiferin and Quercetin Supplementation in Cycling Athletes. Scandinavian Journal of Medicine & Science in Sports. 2025. doi:10.1111/sms.70148
BibTeX
@article{Mazza2025,
author = {Mazza, Oscar Brogaard and Lundby, Carsten and Gejl, Kasper Degn},
title = {No Performance Benefits of Combined Mangiferin and Quercetin Supplementation in Cycling Athletes},
journal = {Scandinavian Journal of Medicine & Science in Sports},
year = {2025},
doi = {10.1111/sms.70148}
}
EUVIMED